San Antonio Breast Cancer Symposium Abstracts2View™: Title Index


		PDA Options: To view abstract content with the ability to bookmark to set up an itinerary that you can download and save to your PDA or computer, click on MY ITINERARY in the banner above; then proceed by searching the online database.

Supported by an educational grant from GlaxoSmithKline

Titles Index

Click on one of the following letters below to display a list of alphabetized titles.
Click the checkbox next to each item to bookmark.

# - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

A

Page: 1 2 3 4 5

[2033] A BRCA1 or BRCA2 mutation and young age predict fast breast cancer growth. Implications for screening?

[2062] A cohort study of the total health care costs for modern treatment of disseminated breast cancer.

[3099] A combined proteomic and microarray screening approach for the identification of proteins associated with radiotherapy resistance in breast cancer cells.

[6033] A community-based single institution registry study of treatment outcomes in breast cancer patients with 4 or more positive lymph nodes.

[1022] A comparison study between multidetector-row CT and histopathological findings in terms of the extension diagnosis of breast cancer.

[6042] A comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population.

[1080] A descriptive study of pharmacokinetic alterations of epirubicin as a function of body size.

[1030] A double-blind randomized controlled trial of paracetamol as a pre-medication for mammography.

[6047] A family history of breast or ovarian cancer further increases the risk of secondary leukemia, especially chronic leukemia, in breast cancer patients.

[3073] A feasibility study of capecitabine monotherapy for elderly patients with high risk early breast cancer.

[2004] A high ratio of 17HSD1/17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer.

[6064] A multicenter phase Ib study of the safety, pharmacokinetics, biological activity and clinical efficacy of INCB7839, a potent and selective inhibitor of ADAM10 and ADAM17.

[1081] A multicenter, randomized, double-blind, parallel-group phase II study of gefitinib (IRESSA) or placebo in combination with docetaxel, as first-line treatment in patients with metastatic breast cancer.

[1003] A new approach to studying the progression of mammary gland carcinoma in mice: high resolution MRI of early cancer and DCIS.

[102] A new system for enrichment and detection of circulating tumor cells in the peripheral blood of patients with metastatic breast cancer.

[6105] A novel anti-Patched1 antibody can suppress hedgehog signaling pathway in human breast carcinoma cells.

[1108] A novel assay to assess the antiangiogenic potential of cytotoxic drugs in human breast cancer.

[6071] A phase 1 study of ARRY-543, a potent, selective, reversible inhibitor of ErbB receptors.

[5072] A phase 2 trial of neoadjuvant letrozole for postmenopausal patients with stage 2 and 3 ER and/or PgR+ breast cancer – endpoint comparisons.

[47] A phase 3 study of the effect of denosumab therapy on bone mineral density in women receiving aromatase inhibitors for non metastatic breast cancer.

Abstract Sessions | Support | FAQ | Privacy Policy

San Antonio Breast Cancer Symposium
7979 Wurzbach Rd., #U-524
San Antonio, TX 78229 USA
http://www.sabcs.org
Technical Support • © 2008 Marathon Multimedia LLC. • All rights reserved